YOLFTbeta
Cleanspace Holdings Ltd

Cleanspace Holdings Ltd

CSX · AU · Healthcare / Medical Devices

0.48AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.48
Open0.48
Day Range0.48 – 0.48
52-Week Range0.32 – 0.74
Volume2.55K
Market Cap40.20M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta0.60
50-Day Avg0.4099
200-Day Avg0.4766

About

CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, an intelligent powered air purifying respirator (PAPR) system that provides protection reporting for safety compliance; CleanSpace EX, a PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. It also provides accessories and consumable products, such as masks, filters, and docking stations. The company was founded in 2009 and is based in St Leonards, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Gabrielle O'Carroll
  • Employees53
  • Headquarters39 Herbert Street, St Leonards, NSW, Australia, 2065, Australia
  • Websitehttps://cleanspacetechnology.com

Leadership

  • Ms. Gabrielle O'CarrollChief Executive Officer
  • Ms. Bree GreeffChief Financial Officer
  • Mr. Dan KaoDirector of Innovation & Operations and Executive Director · b. 1978
  • Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAICCompany Secretary · b. 1973

Financials

Income Statement

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.78M7.72M11.22M28.41M49.93M13.36M12.09M15.72M19.76M19.82M
Growth (%)-+61.42%+45.29%+153.13%+75.76%-73.24%-9.47%+30.01%+25.72%+0.29%
Cost of Revenue2.15M5.55M7.84M15.64M9.66M3.61M17.25M4.36M4.99M15.75M
Gross Profit2.64M2.17M3.39M12.77M40.27M9.75M-5.16M11.36M14.78M4.07M
Gross Margin55.10%28.15%30.17%44.94%80.66%73.00%-42.65%72.25%74.76%20.56%
Operating Expense4.69M4.45M5.22M6.09M24.26M24.88M6.69M16.10M16.06M6.44M
Operating Income-2.05M-2.28M-1.83M6.68M16.01M-15.13M-11.85M-4.74M-1.28M-2.37M
Operating Margin-42.84%-29.52%-16.35%23.52%32.08%-113.27%-98.02%-30.17%-6.48%-11.94%
EBITDA-1.82M-2.04M-1.65M7.03M17.15M-14.10M-10.55M-3.49M-824.55K-1.60M
EBITDA Margin-38.06%-26.47%-14.72%24.76%34.34%-105.58%-87.20%-22.21%-4.17%-8.08%
Net Income-1.99M-1.10M-1.06M5.92M11.39M-11.28M-8.13M-3.13M-478.28K-1.25M
Net Income Margin-41.56%-14.20%-9.48%20.85%22.81%-84.45%-67.24%-19.89%-2.42%-6.29%
R&D959.09K1.06M758.91K1.47M1.38M1.53M748.39K806.63K569.56K680.47K
R&D as % of Total Revenue20.04%13.76%6.76%5.17%2.77%11.46%6.19%5.13%2.88%3.43%
Interest Expense0115.24K56.80K99.47K113.35K262.98K240.70K140.72K91.27K148.27K
Interest Expense % of Total Revenue0.00%1.49%0.51%0.35%0.23%1.97%1.99%0.90%0.46%0.75%

Balance Sheet

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.19M8.14M7.66M49.80M50.72M38.36M28.98M26.05M27.57M23.46M
Total Liabilities3.07M3.32M3.87M10.40M9.99M8.60M7.02M6.95M8.41M4.96M
Total Equity2.12M4.82M3.79M39.40M40.73M29.75M21.96M19.10M19.16M18.50M
Cash1.12M4.25M1.81M31.00M22.21M8.22M3.12M2.75M2.52M1.71M
Total Debt2.24M2.34M2.34M2.85M4.38M4.13M4.00M3.45M4.54M1.45M
Net Debt1.12M-1.91M530.31K-28.60M-17.82M-4.09M885.33K698.59K2.02M-263.55K

Cash Flow

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.42M-1.06M-942.12K4.71M13.46M-13.00M-11.96M-1.73M1.11M69.20K
Investing Cash Flow2.02M471.59K-1.50M-1.94M-14.18M-628.00K7.06M2.00M-778.38K-622.07K
Financing Cash Flow-14.67K3.72M-2.69K2.17M16.19M-357.95K-211.49K-637.10K-559.87K-254.56K
Capital Expenditure182.29K180.68K95.42K399.65K1.73M605.83K5.26K30.09K103.23K211.06K
Free Cash Flow-1.60M-1.24M-1.04M4.31M11.73M-13.60M-11.97M-1.76M1.01M-141.86K
FCF to OCF112.88%116.98%110.13%91.51%87.17%104.66%100.04%101.74%90.71%-205.01%

Earnings

Report DateFeb 24, 2021Jun 2, 2021Aug 26, 2021Dec 1, 2021Feb 24, 2022Jun 1, 2022Aug 24, 2022Nov 30, 2022Feb 19, 2023May 31, 2023Aug 29, 2023Nov 29, 2023Feb 22, 2024May 29, 2024Aug 27, 2024Nov 27, 2024Feb 24, 2025May 28, 2025Aug 25, 2025Dec 3, 2025Feb 23, 2026Jun 3, 2026
EPS Estimate0.000.00-0.000.000.00-0.00-0.000.000.000.000.000.000.000.000.000.000.00-0.00
EPS Actual0.170.00-0.020.00-0.070.00-0.080.00-0.060.000.000.000.000.000.000.000.000.000.000.000.020.00
Surprise----------------------
TimingAfter-hours-After-hours-After-hours-After-hours-After-hours-Pre-market---------Pre-market-

Key Statistics & Ratios

Market Cap40.20M
Enterprise Value24.19M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.03
Price / Book1.77
EPS-0.02
Book Value0.233
Revenue (TTM)19.82M
Gross Profit (TTM)14.79M
EBITDA-2.23M
Profit Margin-6.29%
Operating Margin-10.28%
Return on Equity-6.63%
Return on Assets-6.30%
Shares Outstanding82.04M
Shares Float49.46M
Beta0.60
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%